AYOBAMMY & CO LIMITED
Opportunity 74/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2024-10-31 | 2023-10-31 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (19 events)Click to expand
- 2025-07-28📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2025-04-30📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2024-07-29📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2023-07-31📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2022-07-28📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-12-13📄termination-secretary-company-with-name-termination-dateofficers · TM02
- 2021-08-05📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-09-03📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-07-17📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-09-10📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2018-06-27📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-05-10➖CHAN, Mun Choong, Mr. resignedsecretary
- 2017-06-22📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2017-04-07📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2016-05-06📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2015-11-24📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2015-10-27➕CHAN, Mun Choong, Mr. appointedsecretary
- 2015-10-09🏢Company incorporatedAs AYOBAMMY & CO LIMITED
- 2015-10-09➕OLADEINDE, Ayobami Michael appointeddirector
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Ayobami Michael Oladeinde Individual · British · DOB 05/1976 · age 50 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · WN postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ABI CASE MANAGEMENT LTD→ 11226462 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| ACTIVE MEDCO LTD→ 15405070 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ANKAM LTD→ 16574357 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ASPIRE THERAPY (NW) LTD→ 13969136 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ATC HEALTH LTD→ 14269166 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AUGUSTA MLAY CONCEPTS LIMITED→ 08957972 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| AXIS HEALTH LTD→ 13356188 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AXIS HEALTH SOLUTIONS LTD→ 13081477 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| BANDARU LIMITED→ 13852114 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| BANKEY HEALTH LIMITED→ 11898125 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| BARKS AND RECREATION LIMITED→ 09813502 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| BARTOX AESTHETICS LTD→ 11246641 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 1 resigned)
Click a director name to see their full track record across all companies.